Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

AMAG Pharmaceuticals obtains option to acquire digoxin immune fab for pre-eclampsia

July 23, 2015

Erum Biotechnologies patents PTP-1B inhibitors

July 23, 2015

Alectos Therapeutics designs GCase inhibitors

July 23, 2015

BioRestorative Therapies to evaluate encapsulation technology for use in metabolic program

July 23, 2015

Evolocumab becomes first PCSK9 inhibitor approved in the world

July 22, 2015

Cadila divulges FFAR1 agonists

July 21, 2015

ArmaGen opens enrollment in phase I study of AGT-181 for MPS I

July 20, 2015

Altamira Bio acquires NIH license and CRADAs for ManNAc

July 20, 2015

Merck & Co patents CETP inhibitors

July 17, 2015

Bayer presents GnRH receptor antagonists

July 17, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 7, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026